We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

9 hedge funds and large institutions have $151K invested in Edesa Biotech in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

13% more funds holding

Funds holding: 8 → 9 (+1)

0.24% less ownership

Funds ownership: 0.56% → 0.32% (-0.24%)

91% less capital inflows, than outflows

Capital inflows: $8.16K | Capital outflows: $88.9K

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$6.02K
2
UBS Group
UBS Group
Switzerland
+$1.52K
3
Advisor Group
Advisor Group
Arizona
+$544
4
Bank of America
Bank of America
North Carolina
+$36
5
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services
Florida
+$36

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$59.5K
2
Renaissance Technologies
Renaissance Technologies
New York
-$29.5K

EDSA Hedge Fund Activity: Q3 2019 in Review

9 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2019, worth a combined $151K — down 46% from $280K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EDSA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $6.02K. The largest seller was Morgan Stanley, cutting an estimated $59.5K.

  • 9 institutional investors held Edesa Biotech (EDSA) as of Q3 2019, up from 8 in Q2 2019.
  • Funds reported $151K of Edesa Biotech stock for Q3 2019, down 46% quarter-over-quarter.
  • 2 funds opened new Edesa Biotech positions in Q3 2019 and 1 closed out, a net change of +1 holder.
  • The largest Edesa Biotech buyer in Q3 2019 was Deutsche Bank, an estimated $6.02K added.
  • The largest Edesa Biotech seller in Q3 2019 was Morgan Stanley, an estimated $59.5K sold.

Based on aggregated 13F filings for Q3 2019.